[HTML][HTML] Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways

Y Zhang, L Zhang, X Fan, W Yang, B Yu, J Kou… - Biomedicine & …, 2019 - Elsevier
Captopril (Cap) as angiotensin-converting enzyme inhibitor (ACEi) is commonly used to
treat hypertension and some types of congestive heart failure. However, few studies …

Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways.

Y Zhang, L Zhang, X Fan, W Yang, B Yu… - Biomedicine & …, 2019 - europepmc.org
Captopril (Cap) as angiotensin-converting enzyme inhibitor (ACEi) is commonly used to
treat hypertension and some types of congestive heart failure. However, few studies …

[引用][C] Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways

Y Zhang, L Zhang, X Fan, W Yang, B Yu… - Biomedicine & …, 2019 - cir.nii.ac.jp

Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways

Y Zhang, L Zhang, X Fan, W Yang… - Biomedicine & …, 2019 - pubmed.ncbi.nlm.nih.gov
Captopril (Cap) as angiotensin-converting enzyme inhibitor (ACEi) is commonly used to
treat hypertension and some types of congestive heart failure. However, few studies …